The sooner, the better: More evidence that early antiretroviral therapy lowers viral reservoirs in HIV-Infected Infants

Journal of Infectious Diseases

Volumn 210, Issue 10, 2014, Pages 1519-1522

  Li, Jonathan Z ^a,b   Gandhi, Rajesh T ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA; ANTIRETROVIRUS AGENT;

AGE DISTRIBUTION; ANTIRETROVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; MEMORY T LYMPHOCYTE; NONHUMAN; NOTE; ONSET AGE; PERINATAL PERIOD; TREATMENT DURATION; TREATMENT RESPONSE; VIROGENESIS; VIROTHERAPY; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; FEMALE; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; MALE; PROVIRUS; SECONDARY PREVENTION; VIROLOGY;

ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PROVIRUSES; SECONDARY PREVENTION; VIRAL LOAD;

EID: 84912078677     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu298     Document Type: Note

References (34)

1. UNAIDS. Together we will end AIDS. Geneva, 2012.
2. UNAIDS. Global Report: UNAIDS report on the global AIDS epidemic 2013. Geneva, 2013.
3. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008; 359:2233-44.
4. Abrams EJ, Wiener J, Carter R, et al. Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children. AIDS 2003; 17:867-77.
5. Goetghebuer T, Haelterman E, Le Chenadec J, et al. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS 2009; 23:597-604.
6. Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric infection. http://aidsinfo.nih.gov/contentfiles/lvguidelines/pediatricguidelines. pdf. Accessed 8 May 2014.
7. Persaud D, Siberry GK, Ahonkhai A, et al. Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads. J Virol 2004; 78:968-79.
8. Cotton MF, Violari A, Otwombe K, et al. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet 2013; 382:1555-63.
9. Chun TW, Engel D, Berrey MM, Shea T, Corey L, Fauci AS. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A 1998; 95:8869-73.
10. Siliciano JD, Kajdas J, Finzi D, et al. Longterm follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 2003; 9:727-8.
11. Hutter G, Nowak D, Mossner M, et al. Longterm control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009; 360:692-8.
12. Persaud D, Gay H, Ziemniak C, et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med 2013; 369:1828-35.
13. Persaud D, Deveikis A, Gay H, et al. Very early combination antiretroviral therapy in perinatal HIV-1 infection: two case studies [abstract 75LB]. Presented at: Conference on Retroviruses and Opportunistic Infections, Boston, MA, 3-6 March 2014.
14. ShearerWT, Rosenblatt HM, Gelman RS, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 2003; 112:973-80.
15. Ananworanich J, Puthanakit T, Suntarattiwong P, et al. Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children. AIDS 2014; 28:1015-20.
16. Luzuriaga K, Tabak B, Garber M, et al. HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment. J Infect Dis 2014; 210: 1529-98.
17. Riddler S, Aga E, Bosch RJ, et al. Pre-ART HIV-1 RNA as well as on-treatment CD8 count and CD4/CD8 ratio predict residual viremia on ART [abstract 425LB]. Presented at: Conference on Retroviruses and Opportunistic Infections, Boston, MA, 3-6 March 2014.
18. Chun TW, Justement JS, Pandya P, et al. Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1- infected individuals receiving long-term highly active antiretroviral therapy. J Infect Dis 2002; 185:1672-6.
19. Fourati S, Flandre P, Calin R, et al. Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy. J Antimicrob Chemother 2014; 69:753-6.
20. Chun TW, Nickle DC, Justement JS, et al. Persistence of HIV in gut-Associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis 2008; 197:714-20.
21. Yukl SA, Gianella S, Sinclair E, et al. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. J Infect Dis 2010; 202:1553-61.
22. Ananworanich J, Vandergeeten C, Chomchey N, Chomont N. Early ART intervention restricts the seeding of the HIV reservoir in long-lived central memory CD4 T cells (Abstract 47). Presented at: 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, 3-6 March 2013.
23. Jain V, Hartogensis W, Bacchetti P, et al. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis 2013; 208:1202-11.
24. Strain MC, Little SJ, Daar ES, et al. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis 2005; 191:1410-8.
25. Buzon MJ, Pereyra F, Martin-Gayo E, et al. Long-term antiretroviral treatment initiated in primary HIV-1 infection affects the size, composition and decay kinetics of the reservoir of HIV-1 infected CD4 T cells. J Virol 2014. In press.
26. Hocqueloux L, Avettand-Fenoel V, Jacquot S, et al. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. J Antimicrob Chemother 2013; 68:1169-78.
27. Hunt PW, Martin JN, Sinclair E, et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003; 187:1534-43.
28. Gandhi RT, Spritzler J, Chan E, et al. Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J Acquir Immune Defic Syndr 2006; 42:426-34.
29. Hurst J, Williams J, Hamlyn E, et al. HIV DNA in PHI associates with T cell immunity and predicts disease progression and rebound viremia [abstract 47]. Presented at: Conference on Retroviruses and Opportunistic Infections, Boston, MA, 3-6 March 2014.
30. Saez-Cirion A, Bacchus C, Hocqueloux L, et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog 2013; 9:e1003211.
31. Chun TW, Justement JS, Murray D, et al. Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication. AIDS 2010; 24: 2803-8.
32. Henrich TJ, Hu Z, Li JZ, et al. Long-term reduction in peripheral blood HIV-1 Reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J Infect Dis 2013; 207:1694-702.
33. Henrich TJ. HIV-1 rebound following allogeneic stem cell transplantation and treatment interruption (Abstract 144LB). Presented at: Conference on Retroviruses and Opportunistic Infections, Boston, MA, 3-6 March 2014.
34. Samson LM, Brophy J, Bitnum A, et al. Is functional HIV cure possible following perinatal infection? A cautionary tale [abstract O067]. Presented at: 23rd Annual Canadian Conference on HIV/AIDS Research, St. Johns, Canada, 1-4 May 2014.